| Name | Title | Contact Details |
|---|
Bayer MaterialScience is the global market leader in polyurethanes. The company develops and produces the components for rigid and flexible foams as well as for solid materials. Diverse applications range from mattresses and ski boots to insulating materials for refrigeration appliances and buildings. Bayer MaterialScience is also the leader in the development and production of polycarbonates. Lightweight, tough and freely formable, these high-performance plastics can be used in a wide variety of applications, including in the automotive and construction industries. Bayer MaterialScience is also one of the world’s leading suppliers of raw materials for coatings, adhesives and sealants. These products protect and enhance the appearance of such things as automobiles and furniture, and are used in the sports and leisure sector. In addition, Bayer MaterialScience supplies the chemical industry with numerous basic chemicals.
Health Plus Management Services, LLC (“Health Plus”) provides the most effective solutions for physicians who wish to outsource their practice`s non-medical functions. Our experienced and knowledgeable employees manage the daily non-medical operations for independently-owned physician practices throughout New York. Through a variety of marketing and advertising initiatives, we also raise awareness of our clients` practices and the field of physical medicine and rehabilitation. We provide our services strictly to physicians who are dedicated to providing high quality care.
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Integrity Home Health Care Services is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.